Physician profile
Stephen D Dingley
NPI 1093166456
$5,734.64
in general payments reported to CMS, 2019-2025
18 companies · $1,628 in 2025
The $1,628 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,142 · 2020: $142 · 2021: $190 · 2022: $964 · 2023: $272 · 2024: $396 · 2025: $1,628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,361 · Food and Beverage: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,360.61 |
| Food and Beverage | $935.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,604.88 | 2019-2025 | Medline, Ribfix Titan, Advantagerib |
| Boston Scientific Corporation | $1,223.53 | 2019-2021 | |
| Medtronic, INC. | $325.95 | 2022-2024 | Signia |
| Ethicon US, LLC | $305.22 | 2019-2021 | |
| Davol INC. | $215.02 | 2023-2025 | Progel Applicator Spray Tips, Phasix Mesh |
| Kls-Martin L.P. | $185.89 | 2020-2022 | |
| Acell, INC. | $144.78 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $124.74 | 2024 | Opdivo |
| Astrazeneca Pharmaceuticals Lp | $115.14 | 2024 | Imfinzi |
| Atricure, INC. | $107.83 | 2023 | |
| W. L. Gore & Associates, INC. | $99.95 | 2019 | |
| Integra Lifesciences Corporation | $87.65 | 2020 | |
| Intuitive Surgical, INC. | $70.35 | 2021-2022 | |
| Tei Medical INC. | $63.86 | 2019 | |
| Smith+Nephew, INC. | $20.52 | 2023 | Stravix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $15.35 | 2019 | |
| On Target Laboratories, INC | $12.08 | 2025 | Cytalux |
| Merck Sharp & Dohme LLC | $11.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Dingley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.